90 results
20-F/A
2023 FY
EX-4.87
IPCIF
Intellipharmaceutics International Inc.
6 Feb 24
Annual report (foreign) (amended)
12:00am
in breach hereof, whether directly or indirectly, would cause irreparable injury to the disclosing party and the disclosing party will, in addition to any
20-F/A
2023 FY
IPCIF
Intellipharmaceutics International Inc.
6 Feb 24
Annual report (foreign) (amended)
12:00am
and disposal of hazardous materials and waste products. It is possible that accidental injury or contamination from these materials may occur … is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury
6-K
EX-99.1
IPCIF
Intellipharmaceutics International Inc.
16 Oct 23
Current report (foreign)
5:23pm
for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury and fibromyalgia
6-K
EX-99.1
IPCIF
Intellipharmaceutics International Inc.
26 Sep 23
Current report (foreign)
5:29pm
neuropathy, postherpetic neuralgia, spinal cord injury and fibromyalgia. A controlled-release version of pregabalin should reduce the number of doses
6-K
EX-99.1
IPCIF
Intellipharmaceutics International Inc.
26 Sep 23
Current report (foreign)
5:23pm
for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury and fibromyalgia
6-K
EX-99.1
3zk14qh qn8548
14 Oct 22
Current report (foreign)
4:22pm
6-K
EX-99.1
5donx33fuihgwx m4i9c
21 Jul 22
Current report (foreign)
5:28pm
20-F/A
xxa4f8 haapygab6bv
6 May 22
Annual report (foreign) (amended)
7:54pm
6-K
EX-99.1
adkeh zz9ch54
14 Apr 22
Current report (foreign)
4:46pm
6-K
EX-99.1
pg9odu7o sul6pd8xwpg
1 Mar 22
Current report (foreign)
8:04am
6-K
EX-99.1
w04c s25efjyblz9f3
28 Feb 22
Primary Document
9:56pm
6-K
EX-99.1
eahn5g8u
15 Oct 21
Current report (foreign)
5:22pm
6-K
EX-99.1
v0subn
15 Jul 21
Primary Document
4:45pm
6-K
EX-99.1
cv2 hj6ssx7369y
14 Apr 21
Primary Document
7:50am
6-K
EX-99.1
khs sggs8hv9apkk0lvc
1 Mar 21
Primary Document
8:21am
6-K
EX-99.1
yt3zv4t16 t4
1 Mar 21
Primary Document
8:20am